Takeda Pharmaceutical (TAK) Beginning Cash Balance: 2017-2025

Historic Beginning Cash Balance for Takeda Pharmaceutical (TAK) over the last 9 years, with Mar 2025 value amounting to $2.9 billion.

  • Takeda Pharmaceutical's Beginning Cash Balance fell 18.29% to $2.5 billion in Q1 2025 from the same period last year, while for Mar 2025 it was $2.5 billion, marking a year-over-year decrease of 18.29%. This contributed to the annual value of $2.9 billion for FY2025, which is 24.49% down from last year.
  • Takeda Pharmaceutical's Beginning Cash Balance amounted to $2.9 billion in FY2025, which was down 24.49% from $3.9 billion recorded in FY2024.
  • Over the past 5 years, Takeda Pharmaceutical's Beginning Cash Balance peaked at $8.9 billion during FY2022, and registered a low of $2.9 billion during FY2025.
  • Its 3-year average for Beginning Cash Balance is $4.4 billion, with a median of $3.9 billion in 2024.
  • Per our database at Business Quant, Takeda Pharmaceutical's Beginning Cash Balance surged by 44.51% in 2022 and then slumped by 39.91% in 2024.
  • Yearly analysis of 5 years shows Takeda Pharmaceutical's Beginning Cash Balance stood at $6.1 billion in 2021, then spiked by 44.51% to $8.9 billion in 2022, then dropped by 27.11% to $6.5 billion in 2023, then tumbled by 39.91% to $3.9 billion in 2024, then decreased by 24.49% to $2.9 billion in 2025.